Anti-GRAMD2B monoclonal antibody

Pre-made anti-GRAMD2B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GRAMD2B/GRAMD2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0944-Ab-1/ GM-Tg-hg-IP0944-Ab-2Anti-Human GRAMD2B monoclonal antibodyHuman
GM-Tg-rg-IP0944-Ab-1/ GM-Tg-rg-IP0944-Ab-2Anti-Rat GRAMD2B monoclonal antibodyRat
GM-Tg-mg-IP0944-Ab-1/ GM-Tg-mg-IP0944-Ab-2Anti-Mouse GRAMD2B monoclonal antibodyMouse
GM-Tg-cynog-IP0944-Ab-1/ GM-Tg-cynog-IP0944-Ab-2Anti-Cynomolgus/ Rhesus macaque GRAMD2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0944-Ab-1/ GM-Tg-felg-IP0944-Ab-2Anti-Feline GRAMD2B monoclonal antibodyFeline
GM-Tg-cang-IP0944-Ab-1/ GM-Tg-cang-IP0944-Ab-2Anti-Canine GRAMD2B monoclonal antibodyCanine
GM-Tg-bovg-IP0944-Ab-1/ GM-Tg-bovg-IP0944-Ab-2Anti-Bovine GRAMD2B monoclonal antibodyBovine
GM-Tg-equg-IP0944-Ab-1/ GM-Tg-equg-IP0944-Ab-2Anti-Equine GRAMD2B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0944-Ab-1/ GM-Tg-hg-IP0944-Ab-2; GM-Tg-rg-IP0944-Ab-1/ GM-Tg-rg-IP0944-Ab-2;
GM-Tg-mg-IP0944-Ab-1/ GM-Tg-mg-IP0944-Ab-2; GM-Tg-cynog-IP0944-Ab-1/ GM-Tg-cynog-IP0944-Ab-2;
GM-Tg-felg-IP0944-Ab-1/ GM-Tg-felg-IP0944-Ab-2; GM-Tg-cang-IP0944-Ab-1/ GM-Tg-cang-IP0944-Ab-2;
GM-Tg-bovg-IP0944-Ab-1/ GM-Tg-bovg-IP0944-Ab-2; GM-Tg-equg-IP0944-Ab-1/ GM-Tg-equg-IP0944-Ab-2
Products NameAnti-GRAMD2B monoclonal antibody
Formatmab
Target NameGRAMD2B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GRAMD2B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0944-Ag-1Recombinant multi-species GRM2B/ GRAMD2B/ GRAMD3 protein
    ORF Viral VectorpGMLP003344human GRAMD2B Lentivirus plasmid
    ORF Viral VectorvGMLP003344human GRAMD2B Lentivirus particle


    Target information

    Target IDGM-IP0944
    Target NameGRAMD2B
    Gene ID65983,107022,307288,702639,474662,101086034,505627,100063823
    Gene Symbol and Synonyms9030613F08Rik,9130427A09Rik,GRAMD2B,GRAMD3,NS3TP2,RGD1311016
    Uniprot AccessionQ96HH9,Q5FVG8
    Uniprot Entry NameGRM2B_HUMAN,GRM2B_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000155324
    Target ClassificationN/A

    The target: GRAMD2B, gene name: GRAMD2B, also named as GRAMD3, NS3TP2. Enables identical protein binding activity. Located in cytoplasmic microtubule. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.